[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-469163-105":59,"doc-detail-469163-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","apobec3c-suppresses-prostate-cancer-by-regulating-key-molecules-involved-in-cellular-inflammation-cell-cycle-arrest-and-dna-damage-response","APOBEC3C Suppresses Prostate Cancer by Regulating Key Molecules Involved in Cellular Inflammation, Cell Cycle Arrest, and DNA Damage Response","","Advanced, therapy-resistant prostate cancer presents a persistent clinical challenge, motivating search for actionable molecular drivers. Using transcriptomic datasets from TCGA and GEO with WGCNA, differential expression, and LASSO regression, APOBEC3C (A3C) emerged as a key candidate. Low A3C expression associated with advanced T stage, higher Gleason scores, and poorer survival, and linked to an anti-tumor immune microenvironment. Cell-based experiments showed A3C overexpression inhibited proliferation, migration, and invasion, whereas knockdown promoted malignancy. Mechanistically, A3C increased STING1 and downstream effectors involved in caspase-1–mediated cytokines, DNA damage protection, and GAS1-mediated cell-cycle regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/apobec3c-suppresses-prostate-cancer-by-regulating-key-molecules-involved-in-cellular-inflammation-cell-cycle-arrest-and-dna-damage-response/469163/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/apobec3c-suppresses-prostate-cancer-by-regulating-key-molecules-involved-in-cellular-inflammation-cell-cycle-arrest-and-dna-damage-response/469163.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What did the study identify as a key candidate in prostate cancer?","Question",{"text":112,"@type":113},"APOBEC3C (A3C) was identified as a key molecular candidate using transcriptomic analysis with WGCNA, differential expression, and LASSO regression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is A3C expression related to clinical outcomes?",{"text":117,"@type":113},"Downregulated A3C in prostate cancer correlated with advanced T stage, higher Gleason scores, and worse survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects did A3C have on prostate cancer cell behavior and mechanisms?",{"text":121,"@type":113},"A3C overexpression suppressed proliferation, migration, and invasion, while knockdown promoted these malignant phenotypes. Mechanistically, A3C enhanced STING1 signaling and downstream molecules involved in DNA damage response and cell-cycle regulation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},469163,1791450067,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nAPOBEC3C Suppresses Prostate Cancer by Regulating Key Molecules Involved in Cellular Inflammation, Cell Cycle Arrest, and DNA Damage Response  \nZhongqi Pang 1,2,†, Jianshe Wang 1,3,†, Yidan Xu 4, Bo Ji 1, Minghua Ren 1, * and Beichen Ding 1, *  \nAcademic Editor: Ke Chen  \nReceived: 28 November 2025  \nRevised: 30 December 2025  \nAccepted: 2 January 2026  \nPublished: 3 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Urology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China; [2021020849@hrbmu.edu.cn](2021020849@hrbmu.edu.cn) (Z.P.); [wangjianshe0406@hrbmu.edu.cn](wangjianshe0406@hrbmu.edu.cn) (J.W.); [2022020903@hrbmu.edu.cn](2022020903@hrbmu.edu.cn) (B.J.)  \n2 Department of Pancreatic and Biliary Surgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China  \n3 Department of Urology, Yinfeng (Jinan) Hospital, Jinan 250014, China  \n4 Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China; [2022020675@hrbmu.edu.cn](2022020675@hrbmu.edu.cn)  \n* Correspondence: [002051@hrbmu.edu.cn](002051@hrbmu.edu.cn) (M.R.); [dingbeichen@hrbmu.edu.cn](dingbeichen@hrbmu.edu.cn) (B.D.)† These authors contributed equally to this work.  \nSimple Summary  \nGiven the clinical challenge of advanced, therapy-resistant prostate cancer (PCa), this study aimed to identify novel molecular drivers. Using transcriptomic data from the TCGA and GEO databases, combined with WGCNA, differential expression analysis, and LASSO regression, APOBEC3C (A3C) was identified as a key candidate, whose downregulation in PCa tumors correlated with advanced T stage, higher Gleason scores, and poor survival. Bioinformatic analysis linked high A3C expression to an anti-tumor immune microenvironment (e.g., increased CD8+ T cell infiltration and reduced M2 macrophages) . In vitro assays confirmed that A3C overexpression suppressed PCa cell proliferation, migration, and invasion, while its knockdown promoted these malignant phenotypes. Mechanistically, A3C enhances the expression levels of STING1 and its downstream molecules, including Caspase1, IL-18, and IL-1β, upregulating DNA damage protective genes (GSTP1 and GPX3) and enhancing cell cycle regulator GAS1 expression. Collectively, this study establishes A3C as a PCa suppressor that impedes tumor progression via multiple key pathways.  \nAbstract  \nBackground: Prostate cancer (PCa) is a prevalent malignancy with a rising incidence. Advanced PCa, often resistant to therapy, remains a major clinical challenge, underscoring the need to identify novel molecular drivers. Methods: Utilizing transcriptomic data from the TCGA and GEO databases, we identified APOBEC3C (A3C) as a key candidate through WGCNA, differential expression analysis, and LASSO regression. Its clinical relevance was assessed via Kaplan–Meier survival analysis. Then, we validated A3C expression patterns using immunohistochemistry and Western blot in normal and malignant prostate cell lines. The functional effects of A3C on proliferation, migration, and invasion and mechanisms of such were evaluated through in vitro gain-and loss-of-function assays (CCK-8, Ki67 staining, wound healing, Transwell, Western blot, etc.) . Results: A3C was significantly downregulated in PCa, and this low expression strongly correlated with adverse clinicopathological features, including advanced T stage, higher Gleason scores, and worse survival. Bioinformatically, high A3C expression was associated with an activated anti-tumor immune microenvironment, characterized by enhanced CD8+ T cell infiltration, reduced M2 macrophage abundance, and upregulation of the immune checkpoint CD40 .  \nIn vitro, A3C overexpression effectively suppressed PCa cell proliferation, migration, and invasion, while its kn","cbCaipH26RJeJ7lJ","https://ap.wps.com/l/cbCaipH26RJeJ7lJ","pdf",3884908,23,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What did the study identify as a key candidate in prostate cancer?\",\"answer\":\"APOBEC3C (A3C) was identified as a key molecular candidate using transcriptomic analysis with WGCNA, differential expression, and LASSO regression.\"},{\"question\":\"How is A3C expression related to clinical outcomes?\",\"answer\":\"Downregulated A3C in prostate cancer correlated with advanced T stage, higher Gleason scores, and worse survival.\"},{\"question\":\"What effects did A3C have on prostate cancer cell behavior and mechanisms?\",\"answer\":\"A3C overexpression suppressed proliferation, migration, and invasion, while knockdown promoted these malignant phenotypes. Mechanistically, A3C enhanced STING1 signaling and downstream molecules involved in DNA damage response and cell-cycle regulation.\"}]","APOBEC3C Suppresses Prostate Cancer by Regulating Key Molecules Involved in Cellular Inflammation, Cell Cycle Arrest, and DNA Damage Response | PDF",1790775184,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/b0bcda0e453871a4924cfe939cef8464.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/21336c93fecc266f9948bb827465c47f.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/7005cf76ea534615b661f6a115c2706c.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/14525f188550ab3c69b4087c1d113a57.webp",980,1385]